All the news
Evolucare and UMAMI sign a strategic partnership to promote OphtAI in the german market
Evolucare and Umami-Ware are proud to announce their partnership to promote the OphtAI solution in Germany. Integrated with the Umami-View solution, a new generation ERP dedicated to the optometrists and opticians, OphtAI completes a high value-added offer for ...
Happy new year !
With a New Year come new hopes ! OphtAI wishes you a wonderful Year 2022 ! We are currently setting the stage for great things right now. Follow us to stay tuned !
Meet us at Arab Health 2022 !
Meet Evolucare and its partner Fattal at the Arab Health Dubai, January 24-27, 2022 EVOLUCARE TECHNOLOGIES and its partner Fattal are delighted to welcome you on their booth S1H55 during Arab Health Exhibition Congress. Come and share your projects with ...
The Register : Bruno LaĂż’s interview about ADA Diabetes Care study
OPHTAI WAS INVOLVED IN A LARGE TELERETINAL SCREENING PROGRAM ORGANIZED BY UNIVERSITY OF WASHINGTON TO ASSESS DIABETIC RETINOPATHY ON 23,724 PATIENTS AT HOSPITALS IN SEATTLE AND ATLANTA On January 7, 2021, Aaron Lee's article in the ADA Diabetes Care was ...
Press Release: another successful world challenge for OphtAI
OphtAI is very proud to be one of the 5 AI solutions selected for a real world validation study performed by Pr. Aaron Lee and published in the prestigious ADA Diabetes Care Journal. The OphtAI solution is one of the two solutions deemed to be usable in all ...
Join us at Canadian Glaucoma Society
Eye care is evolving to keep on providing the best of care to an ever increasing number of patients. Come and discuss with our panelists new ways of providing care, introducing not only new technology such as AI but also new ways of working and collaborating.
OphtAI: Proactive Eye Care, Now Possible
World Health Organizationâs recent study, âworld report on vision 2019â revealed that population growth and ageingâalong with lifestyle changes and urbanizationâwill âdramatically increaseâ the number of people with eye conditions, vision impairment, and blindness ...